Emanuel F. Petricoin
Papers
1
Total Citations
114
H-Index
1
About
Emanuel F. Petricoin is a pioneering figure in proteomics and precision medicine, whose work has fundamentally reshaped how we detect and treat cancer. His research centers on serum proteomic profiling and the application of artificial intelligence to decipher complex biological data streams. Petricoin’s most celebrated contribution is the development of AI-driven pattern recognition algorithms that analyze mass spectrometry data to identify cancer-specific protein signatures in the blood. This breakthrough is exemplified by his landmark 2004 study, cited over 114 times, which demonstrated that serum proteomic profiling could accurately discriminate prostate cancer from benign conditions in men with ambiguous PSA levels (2.5–15.0 ng/mL)—a critical advance for reducing unnecessary biopsies. Beyond this, Petricoin is a co-founder of the field of reverse-phase protein microarrays, enabling functional signaling pathway mapping from minute tissue samples. His work has earned him numerous accolades, including the National Institutes of Health Director’s Award, and his technologies are now used in clinical trials worldwide. For students and researchers, Petricoin’s career exemplifies the power of merging computational biology with clinical need, offering a blueprint for translating molecular insights into tangible diagnostic tools.
Research Focus
Key Achievements
Top Papers
- 1